FR2081371B1 - - Google Patents

Info

Publication number
FR2081371B1
FR2081371B1 FR7045437A FR7045437A FR2081371B1 FR 2081371 B1 FR2081371 B1 FR 2081371B1 FR 7045437 A FR7045437 A FR 7045437A FR 7045437 A FR7045437 A FR 7045437A FR 2081371 B1 FR2081371 B1 FR 2081371B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7045437A
Other languages
French (fr)
Other versions
FR2081371A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2436070A external-priority patent/GB1279877A/en
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of FR2081371A1 publication Critical patent/FR2081371A1/fr
Application granted granted Critical
Publication of FR2081371B1 publication Critical patent/FR2081371B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7045437A 1969-12-17 1970-12-16 Beta-adrenergic blocking propanolamine - derivs Granted FR2081371A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB6141469 1969-12-17
GB2436070A GB1279877A (en) 1969-12-17 1969-12-17 Alkanolamine derivatives

Publications (2)

Publication Number Publication Date
FR2081371A1 FR2081371A1 (en) 1971-12-03
FR2081371B1 true FR2081371B1 (xx) 1974-09-20

Family

ID=26257075

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7045437A Granted FR2081371A1 (en) 1969-12-17 1970-12-16 Beta-adrenergic blocking propanolamine - derivs

Country Status (7)

Country Link
JP (1) JPS5231858B1 (xx)
BE (1) BE760423A (xx)
CH (1) CH544064A (xx)
DE (1) DE2062055C3 (xx)
ES (1) ES386554A1 (xx)
FR (1) FR2081371A1 (xx)
SE (1) SE382324B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1540463A (en) * 1976-10-07 1979-02-14 Ici Ltd Alkanolamine derivatives
SE8003277L (sv) * 1979-05-04 1980-11-05 Continental Pharma Bensimidazolderivat, deras framstellning och anvendning samt kompositioner innehallande dessa derivat
DE3423429A1 (de) * 1984-06-26 1986-01-02 Beiersdorf Ag, 2000 Hamburg Substituierte phenoxyalkylaminopropanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
US6451814B1 (en) * 2000-07-17 2002-09-17 Wyeth Heterocyclic β-3 adrenergic receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1458635A (fr) * 1964-09-30 1966-03-04 Ici Ltd Procédé de fabrication de nouvelles alcanolamines et de leurs dérivés
GB1269775A (en) * 1968-07-18 1972-04-06 Ici Ltd Alkanolamine derivatives
GB1263987A (en) * 1969-05-30 1972-02-16 Allen & Hanburys Ltd Phenethylamine derivatives

Also Published As

Publication number Publication date
DE2062055A1 (de) 1971-06-24
SE382324B (sv) 1976-01-26
DE2062055C3 (de) 1979-01-18
JPS5231858B1 (xx) 1977-08-17
FR2081371A1 (en) 1971-12-03
DE2062055B2 (de) 1978-05-24
CH544064A (fr) 1973-11-15
BE760423A (fr) 1971-06-16
ES386554A1 (es) 1974-02-16

Similar Documents

Publication Publication Date Title
FR2051566B1 (xx)
AU2270770A (xx)
AU429630B2 (xx)
AU450150B2 (xx)
FR2081371B1 (xx)
AU2355770A (xx)
AU442375B2 (xx)
AU427401B2 (xx)
AT308690B (xx)
AU442538B2 (xx)
AU442463B2 (xx)
AU410358B2 (xx)
AU414607B2 (xx)
AU417208B2 (xx)
AU442380B2 (xx)
AU425297B2 (xx)
AU442535B2 (xx)
AU442285B2 (xx)
AU438128B2 (xx)
AU428131B2 (xx)
AU428074B2 (xx)
AU442554B2 (xx)
AU428129B2 (xx)
AU442357B2 (xx)
AU442322B2 (xx)

Legal Events

Date Code Title Description
ST Notification of lapse